Pharmaxis Ltd

Press Releases

2011-December-20	Pharmaxis Files PBAC Minor Resubmission for Bronchitol (in PDF)
2011-December-13	Phase 3 Trial in Bronchiectasis Reaches Recruitment Target (in PDF)
2011-December-13	Results of Retail Entitlement Offer (in PDF)
2011-November-18	Institutional Component of Entitlement Offer (in PDF)
2011-November-16	ProRata Entitlement Offer to Raise up to Approximately $80M (in PDF)
2011-November-9	Pharmaxis Announces PBAC Decision on Bronchitol (in PDF)
2011-October-24	Pharmaxis Announces Positive Bronchitol Opinion for Europe (in PDF)
2011-October-21	Investor Conference Call - Bronchitol EU Re-Examination (in PDF)
2011-October-11	Quarterly Investor Conference Call (in PDF)
2011-September-29	Phase II Trial in Allergic Asthma Completes Recruitment (in PDF)
2011-September-28	European Bronchitol Marketing Application Update (in PDF)
2011-August-22	Re-examination Documents Filed for EU Bronchitol Application (in PDF)
2011-July-19	Quarterly Investor Conference Call (in PDF)
2011-July-12	Bronchitol Resubmitted to Australian PBAC (in PDF)
2011-July-5	Re-examination of Bronchitol Marketing Application Requested (in PDF)
2011-June-27	EU Marketing Authorisation Application Review of Bronchitol (in PDF)
2011-June-24	EU CHMP Confirms Negative Trend Vote on Bronchitol (in PDF)
2011-May-25	Pharmaxis Receives Negative Bronchitol Trend Vote from CHMP (in PDF)
2011-May-24	Investor Conference Call (in PDF)
2011-April-21	Bronchitol Deferred by Australian PBAC (in PDF)
2011-April-12	Pharmaxis Quarterly Investor Conference Call (in PDF)
2011-February-8	Pharmaxis' Bronchitol Receives TGA Approval for Australians with Cystic Fibrosis (in PDF)
2011-January-25	Update: Bronchitol EU Marketing Authorisation for Cystic Fibrosis (in PDF)
2011-January-24	Pharmaxis Quarterly Investor Conference Call (in PDF)
2012	2012 Press Releases
2010	2010 Press Releases
2009	2009 Press Releases
2008	2008 Press Releases
2007	2007 Press Releases
2006	2006 Press Releases
2005	2005 Press Releases
2004	2004 Press Releases